معلومات مباشر
Bahraini Interior Ministry activates sirens across the country
World Health Organization: Ebola Outbreak in Congo Sees Fastest Spread in History
Wall Street declines as technology stocks weigh despite strong earnings
European Organization Plans to Lift Banking Restrictions to Compete with Wall Street
Kuwait Army Detects 32 Hostile Drones in Kuwaiti Airspace
Source: معلومات مباشر
21 HrsReady to play
Ready to play
Abbott Healthcare Technology has raised its profit outlook for 2026 following strong second-quarter results that surpassed Wall Street expectations. The adjusted earnings per share are forecasted to be between $5.45 and $5.60, an increase of five cents from previous estimates. The company's shares rose by 4.2% at the start of trading in New York, easing investor concerns over financial pressures in the healthcare sector. The Medical Devices and Diabetes Care units delivered excellent performance, while the Nutrition division saw a slight decline of about as expected, previously impacted by lawsuits and product recalls. Additionally, sales in the Diagnostics segment, including colorectal cancer testing products, grew by 13.3% after Abbott's acquisition of Exact Sciences, with the company also announcing that an incident of cyber breach did not affect operations or financial results.
Notice: This Is an AI-Generated Summary
Comments (0)